Early Identification of Candida in Intra-abdominal Candidiasis

Plain-language summary

This study examines laboratory methods (calscreener, metabolic profiling, microscopy, RTqPCR) for the early and rapid identification of Candida in intra-abdominal candidiasis. It enrolled adult patients admitted to intensive care with an intra-abdominal infection requiring surgery or drainage. It was conducted as a study without a phase designation and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Central Hospital, Nancy, France

Intervention

calscreener, Metabolic profile, optical microscopy, RTqPCR

Start date

2/17/2022

Estimated completion

6/22/2023

Countries

France

Related genes

Locations

• Vandœuvre-lès-Nancy, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

The criteria belong to the pBDG2 study (Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients).

Inclusion Criteria:

* adult
* Covered by health insurance
* Admitted in ICU with intra-abdominal infection requiring abdominal surgery or percutaneous drainage

Exclusion Criteria:

* Pregnant or lactating woman
* Patient deprived of liberty after administration of juridical decision
* Patient under psychiatric care